Assignee
PRIEBE WALDEMAR
US·9 granted patents·2 pending applications·75 citations·filing 1995–2012
Top patents by PatentIndex Score
11 records- 0194US8143412B2Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)PRIEBE WALDEMAR·Filed 2009·Granted Mar 27, 2012·27 cites·9 claims
- 0288US8299033B2Iodo-hexose compounds useful to treat cancerPRIEBE WALDEMAR·Filed 2009·Granted Oct 30, 2012·14 cites·7 claims
- 0386US8450337B2Methods of treating skin disorders with caffeic acid analogsPRIEBE WALDEMAR·Filed 2009·Granted May 28, 2013·3 cites·6 claims
- 0480US8927506B2Acetates of 2-deoxy monosaccharides with anticancer activityPRIEBE WALDEMAR·Filed 2009·Granted Jan 6, 2015·5 cites·8 claims
- 0575US8779151B2Orally bioavailable caffeic acid related anticancer drugsPRIEBE WALDEMAR·Filed 2007·Granted Jul 15, 2014·2 cites·27 claims
- 0671US8648102B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2012·Granted Feb 11, 2014·1 cites·12 claims
- 0771US8119827B2Compounds for treatment of cell proliferative diseasesPRIEBE WALDEMAR·Filed 2010·Granted Feb 21, 2012·1 cites·16 claims
- 0870US8637675B2Inhibitors of proliferation and activation of signal transducer and activators of transcription (STATS)PRIEBE WALDEMAR·Filed 2012·Granted Jan 28, 2014·1 cites·16 claims
- 0966US5625043AAnthracyclines with unusually high activity against cells resistant to doxorubicin and its analogsPRIEBE WALDEMAR·Filed 1995·Granted Apr 29, 1997·21 cites·19 claims
- 1040US2012276108A1Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseasesPRIEBE WALDEMAR·Filed 2012·Application pending·0 cites
- 1135US2013129675A1Interferon therapies in combination with blockade of stat3 activationPRIEBE WALDEMAR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PRIEBE WALDEMAR files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →